- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Vital Images cuts agreement with Medtronic SNT
Image processing vendor Vital Images has entered into a joint venture with Medtronic Surgical Navigation Technologies. Under the agreement, Vital Images' advanced visualization
Image processing vendor Vital Images has entered into a joint venture with Medtronic Surgical Navigation Technologies. Under the agreement, Vital Images' advanced visualization technology will be integrated into Medtronic SNT's image-guided surgery products. The two companies will also collaborate on new surgical planning software and service offerings. In late December, Vital Images released the latest version of its flagship processing software, Vitrea 2, which converts 2D image data into 3D navigable images for use in disease screening, clinical diagnosis, and therapy planning. The just-released Version 2.6 includes improved quality, reliability, and usability features.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
